Is clopidogrel, prasugrel or ticagrelor – each in combination with acetylsalicylic acid (ASA) – better for preventing atherothrombotic events in adults with acute coronary syndrome undergoing primary or delayed percutaneous coronary intervention (PCI)? According to the less than satisfactory results of a report published by the German Institute for Quality and Efficiency in Health Care (IQWiG), this remains an open question, even though the 3 drugs have been in use for many years. This is because the informative value of the network meta-analysis depends to a large extent on study data that the Institute requested from a drug manufacturer, but did not receive.

https://www.miragenews.com/data-shortage-hinders-meta-analysis-of-heart-1095830/

#miragenews